Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-12-097283
Filing Date
2012-03-06
Accepted
2012-03-05 20:16:01
Documents
14

Document Format Files

Seq Description Document Type Size
1 FORM 424(B)(5) d309840d424b5.htm 424B5 519924
2 GRAPHIC g309840g08f20.jpg GRAPHIC 47674
3 GRAPHIC g309840g10d26.jpg GRAPHIC 15212
4 GRAPHIC g309840g12d74.jpg GRAPHIC 52588
5 GRAPHIC g309840g23k41.jpg GRAPHIC 80333
6 GRAPHIC g309840g34w03.jpg GRAPHIC 16927
7 GRAPHIC g309840g48r20.jpg GRAPHIC 116037
8 GRAPHIC g309840g50o38.jpg GRAPHIC 140824
9 GRAPHIC g309840g56y77.jpg GRAPHIC 101470
10 GRAPHIC g309840g58v46.jpg GRAPHIC 77095
11 GRAPHIC g309840g74a77.jpg GRAPHIC 10826
12 GRAPHIC g309840g86k91.jpg GRAPHIC 104775
13 GRAPHIC g309840g91d00.jpg GRAPHIC 84883
14 GRAPHIC g309840g95a35.jpg GRAPHIC 12044
  Complete submission text file 0001193125-12-097283.txt   1708783
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-172849 | Film No.: 12668488
SIC: 2834 Pharmaceutical Preparations